Decheng Capital LLC Arcellx, Inc. Transaction History
Decheng Capital LLC
- $422 Billion
- Q3 2024
A detailed history of Decheng Capital LLC transactions in Arcellx, Inc. stock. As of the latest transaction made, Decheng Capital LLC holds 21,177 shares of ACLX stock, worth $1.87 Million. This represents 0.42% of its overall portfolio holdings.
Number of Shares
21,177
Previous 1,177
1699.24%
Holding current value
$1.87 Million
Previous $65 Million
2622.47%
% of portfolio
0.42%
Previous 0.02%
Shares
2 transactions
Others Institutions Holding ACLX
# of Institutions
205Shares Held
44.2MCall Options Held
2.23MPut Options Held
907K-
Paradigm Biocapital Advisors LP New York, NY4MShares$354 Million12.04% of portfolio
-
Perceptive Advisors LLC New York, NY3.89MShares$344 Million8.48% of portfolio
-
Nea Management Company, LLC Timonium, MD3.75MShares$332 Million23.89% of portfolio
-
Black Rock Inc. New York, NY3.52MShares$311 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA2.46MShares$218 Million0.0% of portfolio
About Arcellx, Inc.
- Ticker ACLX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 43,819,200
- Market Cap $3.88B
- Description
- Arcellx, Inc., a clinical-stage biotechnology company, engages in the development of various immunotherapies for patients with cancer and other incurable diseases. The company's lead ddCAR product candidate is CART-ddBCMA, which is in phase 1 clinical trial for the treatment of patients with relapsed or refractory (r/r) multiple myeloma (MM). It...